Otsuka (OTCMKTS:OTSKY) Sees Strong Trading Volume – Here’s What Happened

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) shares saw strong trading volume on Wednesday . 80,392 shares traded hands during mid-day trading, an increase of 118% from the previous session’s volume of 36,937 shares.The stock last traded at $36.15 and had previously closed at $34.92.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Zacks Research upgraded shares of Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. The Goldman Sachs Group lowered shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. Morgan Stanley upgraded shares of Otsuka to an “overweight” rating in a research report on Friday, January 23rd. Finally, UBS Group upgraded shares of Otsuka to a “hold” rating in a research report on Tuesday, January 27th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold”.

Otsuka Stock Performance

The stock’s fifty day moving average price is $34.52 and its two-hundred day moving average price is $31.35. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. The company has a market cap of $38.91 billion and a P/E ratio of 15.28.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.16. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. The company had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.78 billion. Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. As a group, equities analysts predict that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 1.86 earnings per share for the current year.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.